TABLE 1.
Baseline Characteristics of Veterans Undergoing Transcatheter Aortic Valve Replacement at Veterans Affairs Transcatheter Aortic Valve Replacement Centers, 2012 to 2017
| All Veterans (N = 959) |
Transfemoral Access (n = 860 [89.7%]) |
Other Access (n = 99 [10.3%]) |
p Value* | |
|---|---|---|---|---|
| Age at TAVR, yrs | 78.1 ± 9.0 | 78.3 ± 9.0 | 76.4 ± 8.3 | 0.04 |
| Male | 939 (97.9) | 842 (97.9) | 97 (98.0) | 0.96 |
| Body mass index, kg/m2 | 29.2 ± 6.2 | 29.2 ± 6.2 | 28.6 ± 6.1 | 0.37 |
| Ethnicity | ||||
| White | 829 (86.4) | 742 (86.3) | 87 (87.9) | 0.66 |
| Black | 53 (5.5) | 50 (5.8) | 3 (3.0) | 0.25 |
| Hawaiian | 15 (1.6) | 12 (1.4) | 3 (3.0) | 0.21 |
| Indian | 7 (0.7) | 7 (0.8) | 0 (0) | 0.37 |
| Asian | 5 (0.5) | 4 (0.5) | 1 (1.0) | 0.48 |
| Hypertension | 915 (95.4) | 818 (95.1) | 97 (98.0) | 0.20 |
| Diabetes | 514 (53.6) | 463 (53.8) | 51 (51.5) | 0.66 |
| Hyperlipidemia | 880 (91.8) | 784 (91.2) | 96 (97.0) | 0.05 |
| Tobacco use (ever) | 549 (57.2) | 487 (56.6) | 62 (62.6) | 0.25 |
| Heart failure | 643 (67.0) | 569 (66.2) | 74 (74.7) | 0.09 |
| Myocardial infarction | 356 (37.1) | 316 (36.7) | 40 (40.4) | 0.48 |
| CABG | 381 (39.7) | 323 (37.6) | 58 (58.6) | <0.001 |
| Valve surgery | 120 (12.5) | 107 (12.4) | 13 (13.1) | 0.84 |
| PCI | 383 (39.9) | 334 (38.8) | 49 (49.5) | 0.04 |
| Chronic kidney disease | 417 (43.5) | 368 (42.8) | 49 (49.5) | 0.20 |
| Dialysis use | 56 (5.8) | 48 (5.6) | 8 (8.1) | 0.32 |
| Chronic lung disease | 445 (46.4) | 386 (44.9) | 59 (59.6) | 0.01 |
| Cerebrovascular disease | 335 (34.9) | 296 (34.4) | 39 (39.4) | 0.33 |
| Peripheral arterial disease | 419 (43.7) | 342 (39.8) | 77 (77.8) | <0.001 |
| Atrial fibrillation | 351 (36.6) | 317 (36.9) | 34 (34.3) | 0.62 |
| Oral anticoagulant use | 152 (15.8) | 135 (15.7) | 17 (17.2) | 0.70 |
Values are mean ± SD or n (%).
*
Chi-square test or Student’s t-test.
CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; TAVR = transcatheter aortic valve replacement.